Gudrun Lenherr,Noemi Csaba,Nomceba Lungile Thwala,Zhigao Niu,Maria José Alonso
申请号：
US15311818
公开号：
US20170087096A1
申请日:
2015.06.12
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Nanocapsule systems of at least one active pharmaceutical ingredient selected from the group consisting of at least one insulin, insulin analogue, insulin derivative, glucagon-like peptide-1 receptor agonist (GLP1 R agonist) and/or dual GLP-1 receptor/glucagon receptor agonist and/or or any combination thereof are disclosed.
